Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-5-17
pubmed:abstractText
Obesity and related diseases are an important and growing health concern in the United States and around the world. Soft drinks and other sugar-sweetened beverages are now the primary sources of added sugars in Americans' diets. The metabolic syndrome is a cluster of common pathologies, including abdominal obesity linked to an excess of visceral fat, fatty liver, insulin resistance, hyperinsulinemia, dyslipidemia, and hypertension. Trends in all of these alterations are related to the consumption of dietary fructose and the introduction of high-fructose corn syrup (HFCS) as a sweetener in soft drinks and other foods. Experimental and clinical evidence suggests a progressive association between HFCS consumption, obesity, and the other injury processes. However, experimental HFCS consumption seems to produce some of the changes associated with metabolic syndrome even without increasing the body weight. Metabolic damage associated with HFCS probably is not limited to obesity-pathway mechanisms.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1534-3111
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
105-12
pubmed:meshHeading
pubmed-meshheading:20424937-Cardiovascular Diseases, pubmed-meshheading:20424937-Dietary Sucrose, pubmed-meshheading:20424937-Energy Intake, pubmed-meshheading:20424937-Energy Metabolism, pubmed-meshheading:20424937-Fatty Liver, pubmed-meshheading:20424937-Fructose, pubmed-meshheading:20424937-Humans, pubmed-meshheading:20424937-Hypertension, pubmed-meshheading:20424937-Inflammation, pubmed-meshheading:20424937-Intra-Abdominal Fat, pubmed-meshheading:20424937-Kidney Diseases, pubmed-meshheading:20424937-Liver Diseases, pubmed-meshheading:20424937-Metabolic Syndrome X, pubmed-meshheading:20424937-Obesity, pubmed-meshheading:20424937-Risk Factors, pubmed-meshheading:20424937-Sweetening Agents, pubmed-meshheading:20424937-United States, pubmed-meshheading:20424937-Weight Gain, pubmed-meshheading:20424937-World Health, pubmed-meshheading:20424937-Zea mays
pubmed:year
2010
pubmed:articleTitle
The role of high-fructose corn syrup in metabolic syndrome and hypertension.
pubmed:affiliation
Department of Physiology and Pharmacology, Ponce School of Medicine, 395 Zona Industrial Reparada 2, Ponce, PR 00716-2348, USA. leferder@psm.edu
pubmed:publicationType
Journal Article, Review